IR-News

AUSSENDER



Singulus Technologies Aktiengesellschaft
Ansprechpartner: Bernhard Krause
Tel.: +49 170 9202924
E-Mail: bernhard.krause@singulus.de

FRüHERE MELDUNGEN

04.08.2021 - 12:15 | Singulus Technologies Aktiengesellschaft
04.08.2021 - 12:10 | Singulus Technologies Aktiengesellschaft
29.07.2021 - 12:24 | Singulus Technologies Aktiengesellschaft
29.07.2021 - 12:24 | Singulus Technologies Aktiengesellschaft
20.07.2021 - 08:15 | Singulus Technologies Aktiengesellschaft

WEITERE IR-NEWS

26.11.2021 - 19:00 | BAWAG Group AG
26.11.2021 - 19:00 | BAWAG Group AG
26.11.2021 - 19:00 | Value Management & Research AG
pta20210804016
Business news for the stock market

Singulus Technologies Aktiengesellschaft: SINGULUS TECHNOLOGIES Receives Significant Order for Medical Technology


Kahl am Main (pta016/04.08.2021/12:20) - Press Release

SINGULUS TECHNOLOGIES Receives Significant Order for Medical Technology

Kahl am Main, 04 August 2021 - The SINGULUS TECHNOLOGIES AG (SINGULUS TECHNOLOGIES) has received a significant order for the delivery of several new processing machines from an internationally operating customer in the medical sector. The order volume is in a low double-digit € range. The prepayment for this order is expected to be received shortly.

Dr.-Ing. Stefan Rinck, CEO of SINGULUS TECHNOLOGIES AG, comments: "Our customer experiences strong demand for its innovative contact lenses and further expands its capacities on the basis of the further developed machine technology by SINGULUS TECHNOLOGIES". Dr. Rinck adds: "Our Life Science segment is developing extremely favorably this year with the orders for Decorative Coatings and several orders for Medical Technology and proves the potential for these application areas targeted by the machines offered by SINGULUS TECHNOLOGIES."

After the successful installation of machines of the MEDLINE type for a site in Asia, this is the continuation of the cooperation and further development of the MEDLINE. The processing machine by SINGULUS TECHNOLOGIES cleans contact lenses from residues and subsequently coats the lenses in the course of an additional processing step.

For medical technology, in addition to the production machines for wet-chemical processes, SINGULUS TECHNOLOGIES also offers methods of vacuum coating technology. With its innovative processes SINGULUS TECHNOLOGIES meets the GMP ("Good Manufacturing Practice") and thus the international rules and regulations. Furthermore, the machines meet the high demands of medical technology.

SINGULUS TECHNOLOGIES – Technologies for a Sustainable World

Responsible and sustainable corporate governance is very important to SINGULUS TECHNOLOGIES. SINGULUS TECHNOLOGIES develops and assembles innovative machines and systems for efficient and resource-saving production processes, which are used worldwide in the solar/hydrogen, semiconductor, medical technology, consumer goods and data storage sectors. SINGULUS TECHNOLOGIES regards sustainability as an opportunity to position itself with innovative products that follow this spirit.

In the focus are:

• environmental awareness

• efficient use of resources

• avoidance of unnecessary CO2 pollution

The company's core competencies include various processes of coating technology (PVD, PECVD), surface treatment and wet-chemical and thermal production processes.

SINGULUS TECHNOLOGIES AG, Hanauer Landstrasse 103,
D-63796 Kahl/Main, WKN A1681X / ISIN DE000A1681X5

Contact:

Maren Schuster, Investor Relations, Tel.: + 49 (0) 160 9609 0279

Bernhard Krause, Corporate Communications, Tel.: +49 (0) 172 833 2224

Email: bernhard.krause@singulus.de (mailto:bernhard.krause@singulus.de)

(end)
emitter: Singulus Technologies Aktiengesellschaft
Hanauer Landstraße 103
63796 Kahl am Main
Germany
contact person: Bernhard Krause
phone: +49 170 9202924
e-mail: bernhard.krause@singulus.de
website: www.singulus.de
stock exchanges: regulated market in Berlin, Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Tradegate
ISIN(s): DE000A1681X5 (share), DE000A2AA5H5 (bond)
|
|
98.414 Abonnenten
|
194.971 Meldungen
|
80.617 Pressefotos
Top